These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22990014)

  • 1. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis.
    Ramos E; Ruchala P; Goodnough JB; Kautz L; Preza GC; Nemeth E; Ganz T
    Blood; 2012 Nov; 120(18):3829-36. PubMed ID: 22990014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload.
    Preza GC; Ruchala P; Pinon R; Ramos E; Qiao B; Peralta MA; Sharma S; Waring A; Ganz T; Nemeth E
    J Clin Invest; 2011 Dec; 121(12):4880-8. PubMed ID: 22045566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
    Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
    Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia.
    Liu J; Liu W; Liu Y; Miao Y; Guo Y; Song H; Wang F; Zhou H; Ganz T; Yan B; Liu S
    Haematologica; 2019 Sep; 104(9):1768-1781. PubMed ID: 30792208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis.
    Lesbordes-Brion JC; Viatte L; Bennoun M; Lou DQ; Ramey G; Houbron C; Hamard G; Kahn A; Vaulont S
    Blood; 2006 Aug; 108(4):1402-5. PubMed ID: 16574947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders.
    Ganz T; Nemeth E
    Hematology Am Soc Hematol Educ Program; 2011; 2011():538-42. PubMed ID: 22160086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin induction limits mobilisation of splenic iron in a mouse model of secondary iron overload.
    Camberlein E; Abgueguen E; Fatih N; Canonne-Hergaux F; Leroyer P; Turlin B; Ropert M; Brissot P; Loréal O
    Biochim Biophys Acta; 2010 Mar; 1802(3):339-46. PubMed ID: 20045050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice.
    Corradini E; Schmidt PJ; Meynard D; Garuti C; Montosi G; Chen S; Vukicevic S; Pietrangelo A; Lin HY; Babitt JL
    Gastroenterology; 2010 Nov; 139(5):1721-9. PubMed ID: 20682319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of HIF-2α in the enterocytes decreases the severity of tissue iron loading in hepcidin knockout mice.
    Mastrogiannaki M; Matak P; Delga S; Deschemin JC; Vaulont S; Peyssonnaux C
    Blood; 2012 Jan; 119(2):587-90. PubMed ID: 22128145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.
    Muckenthaler M; Roy CN; Custodio AO; Miñana B; deGraaf J; Montross LK; Andrews NC; Hentze MW
    Nat Genet; 2003 May; 34(1):102-7. PubMed ID: 12704390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [To prevent and cure the iron overloads, the hopes of hepcidin].
    Viatte L; Vaulont S
    Med Sci (Paris); 2006; 22(8-9):696-8. PubMed ID: 16962038
    [No Abstract]   [Full Text] [Related]  

  • 13. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice.
    Viatte L; Lesbordes-Brion JC; Lou DQ; Bennoun M; Nicolas G; Kahn A; Canonne-Hergaux F; Vaulont S
    Blood; 2005 Jun; 105(12):4861-4. PubMed ID: 15713792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice.
    Nicolas G; Andrews NC; Kahn A; Vaulont S
    Blood; 2004 Apr; 103(7):2841-3. PubMed ID: 14656876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera.
    Casu C; Oikonomidou PR; Chen H; Nandi V; Ginzburg Y; Prasad P; Fleming RE; Shah YM; Valore EV; Nemeth E; Ganz T; MacDonald B; Rivella S
    Blood; 2016 Jul; 128(2):265-76. PubMed ID: 27154187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
    Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
    J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of ferroportin inhibition by minihepcidin PR73.
    Wilbon AS; Shen J; Ruchala P; Zhou M; Pan Y
    PLoS Biol; 2023 Jan; 21(1):e3001936. PubMed ID: 36649314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation.
    Constante M; Jiang W; Wang D; Raymond VA; Bilodeau M; Santos MM
    Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G229-37. PubMed ID: 16565419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin in iron overload disorders.
    Papanikolaou G; Tzilianos M; Christakis JI; Bogdanos D; Tsimirika K; MacFarlane J; Goldberg YP; Sakellaropoulos N; Ganz T; Nemeth E
    Blood; 2005 May; 105(10):4103-5. PubMed ID: 15671438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.
    Nicolas G; Bennoun M; Porteu A; Mativet S; Beaumont C; Grandchamp B; Sirito M; Sawadogo M; Kahn A; Vaulont S
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4596-601. PubMed ID: 11930010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.